Chapter three
moking leads to a multiple dependency. It consists of nicotine
dependency, a substance strongly affecting the brains and in addition,
a psychological and social dependency developing with the smoking
habit. Recent studies have brought new knowledge about the mechanisms
that keep up the physiological dependency caused by nicotine.
Although in smoking cessation psychological and social factors
have an important role, the basic element in the dependency problem
seems to be the consequences of nicotine effects in the central
nervous system.
Smoking is a habit of whose models are adopted in the environment. Especially friends influence strongly when starting to smoke (in the initiation of smoking). Group pressures and identification problems do not comply only to young people. For instance in work society, when others are smoking, this also influences ones own smoking.
When smoking, a person starts to develop various small doings and meeting a smoking friend easily leads to lighting up a cigarette. This social dependency becomes noticeable only in efforts to quit smoking.
For some tobacco is a means to cheer up. Psychological dependency gets explicit, when a person can be without cigarettes for months but in a distressing situation there is an unsurpassable need to light up a cigarette.
These withdrawal symptoms go normally away in a couple of weeks. The strength of nicotine dependency is demonstrated in the fact that the long term effects of smoking cessation are alike with the heroine.
After cessation it takes for several months before the activity of receptors return to the normal level. The tendency to pick up smoking habit is thus big even years after cessation.
The majority of smokers start again within three months from cessation. During this period the sensitivity of receptors is still very high and psychological and social mechanisms related to nonsmoking are not yet learned.
The replacement therapy must be long enough; treatment lasting only for few days or weeks tends to have bad results. How useful is nicotine replacement? This depends on the smoker's motivation, the level of nicotine dependency and the additional support the smoker is receiving during cessation.
The most useful means nicotine replacement therapy is for those who are the most heavy dependant on nicotine. The level of dependency can be evaluated for instance by using the Fageström questionnaire.n
Motivation to stop smoking and confidence in the ability to do so are important predictors of success. Overviews of randomised controlled trials of the effect of brief smoking cessation advice, given by doctors in consultations about other matters, indicate achievement of about 5% long-term (ie at least one year) cessation, compared with less than 1% in non-intervention control groups. Following such advice, about 1 in 20 can therefore be expected to stop, compared with about 1 in 100 otherwise. Higher success rates can be achieved when advice is combined in other interventions, especially nicotine replacement therapy--nicotine gum, skin patches, or nasal spray.
Many randonmised controlled trials have now shown that, in ordinary clinical settings, nicotine replacement therapy can double sustained smoking cessation rates, compared with placebo, and about 1 in 10 can be expected to stop. In a large general practice-based placebo-controlled trial we demonstrated that, using nicotine skin patches, about 1 in 4 of those who achieved cessation for one week using such patches could expect (with continued use of patches for up to three months) to achieve sustained smoking cessation for at least a year.
Essential steps in smoking cessation advice:
This guideline contains strategies and recommendations designed to assist clinicians, smoking cessation specialists, and health care administrators/insurers/purchasers in identifying tobacco users and supporting and delivering effective smoking cessation interventions. These recommendations were made as a result of an exhaustive and systematic review and analysis of the scientific literature. The primary analytic technique used was meta-analysis. The strength of evidence that served as the basis for each recommendation is clearly indicated in the guideline. Public testimony an a peer review were also part of the guideline's development process, as well as a notice in the Federal Register inviting review. The guideline's principal findings are:
The guideline proposes strategies for carrying out each of its specific recommendations.
For clinicians, these recommendations are
(1) systematically identify tobacco users and document their status;
(2) strongly urge all smokers to quit;
(3) identify smokers willing to make a quit attempt;
(4) aid the patient in quitting by helping with a quit plan, offering nicotine replacement therapy, giving advice, and providing supplementary information; and
(5) schedule follow-up contact.
Recommendations for smoking cessation specialists are
(1) assess the smoker who has entered an intervention programme;
(2) use a variety of clinical specialists;
(3) ensure that the programme is sufficiently intensive;
(4) use a variety of programme formats;
(5) include effective counseuing techniques;
(6) target the smoker's motivation to quit;
(7)provide relapse prevention intervention;
(8) offer nicotine replacement therapy;
(9) arrange follow-up contact.
Recommendations for health insurance purchasers and health care administrators are
(1) consider making tobacco assessment, counselling, and treatment a contractual obligation of the insurers and providers that sell services;
(2) ensure that institutional changes to promote smoking cessation interventions are universally implemented.
Source: Dr Thomas E Kottke, Mayo Clinic and Foundation, Rochester, Minnesota, USA